Epirubicin Versus Docetaxel Plus Cyclophosphamide in Lymph Node Negative, ER-positive, Her2-negative Breast Cancer
Clinical trial NCT02549677 · COMPLETED
Trial details
- NCT number
- NCT02549677
- Sponsor
- Ruijin Hospital
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2020-03-01
- Enrollment
- 294
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.